Azure Tariro Makadzange, MD
Infectious Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Makadzange’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C157375 · Current
Licensed to practise in California · since 2018 · expires 2028-07-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$7,762
Medicare paid this office $7,762 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,963 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,747 | $116 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 74 · Women 39% · Also on Medicaid 49% · Health risk score 3.23. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 55% · Coronary heart disease 52% · Diabetes 42% · Depression 39% · Atrial fibrillation 36% · Dementia 36%.
The office billed $31,496, Medicare allowed $9,742 and paid $7,762; for 88 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 88 | 74 | 3.23 | $31,496 | $7,762 |
| 2020 | 13 | 31 | 75 | 2.27 | $8,677 | $2,316 |
| 2016 | 39 | 130 | 65 | 2.97 | $58,063 | $12,918 |
| 2015 | 42 | 159 | 65 | 3.01 | $59,272 | $13,541 |
| 2014 | 16 | 50 | 71 | 2.75 | $16,481 | $3,907 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $6,825 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,818 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,184 | $59 |
2015: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $4,599 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,469 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,680 | $167 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,536 | $59 |
Medicaid work
$990 in 2024
Medicaid paid $990 for 26 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $990 |
| 2024 | 26 | 1 | 12 | $990 |
Money from drug and device companies
$98 in 2025
| 2025 | 1 | 1 | None | $98 |
| 2023 | 1 | 1 | None | $3 |
| 2022 | 1 | 2 | None | $124 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | None | $98 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2025-03-18 | None | $98 |
See earlier years (2023, 2022)
2023: $3
| Merck Sharp & Dohme | None | $3 | 1 payment
|
2022: $124
| Gilead Sciences | Ambisome | $124 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merck Sharp & Dohme LLC · Study Name#Mixed Methods Cross Sectional Study To Evaluate Factors Associated With Vaccination Uptake in Hpv Vaccination Programs for in-School and Out-of-School Vaccine Eligible Populations in Urban and Rural Communities in Zimbabwe · 2024 | Their institution | $94,348 |
| Merck Sharp & Dohme LLC · Study Name#Mixed Methods Cross Sectional Study To Evaluate Factors Associated With Vaccination Uptake in Hpv Vaccination Programs for in-School and Out-of-School Vaccine Eligible Populations in Urban and Rural Communities in Zimbabwe · 2023 | Their institution | $70,761 |
| Merck Sharp & Dohme LLC · A Prospective-Cohort Study To Compare the Immune Response To Respiratory Syncytial Virus and Clinical Outcomes in Patients Who Received Nirsevimab Versus Those Who Had Natural Infection in the Prior Respiratory Season. · 2025 | Their institution | $70,761 |
| Merck Sharp & Dohme LLC · Study Name#Mixed Methods Cross Sectional Study To Evaluate Factors Associated With Vaccination Uptake in Hpv Vaccination Programs for in-School and Out-of-School Vaccine Eligible Populations in Urban and Rural Communities in Zimbabwe · 2025 | Their institution | $4,114 |
Professional record
- NPI
- 1841440716
- Licence
- CA C157375California C157375: Current · expires 2028-07-31
- Trained
- Harvard Medical School, 2005
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-09-26
- NPI last updated
- 2024-04-12
- NPI record certified
- 2024-04-12
This is when the NPI record was last certified, not a medical board exam.